Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Alibaba Health Information Technology ( (HK:0241) ).
Alibaba Health Information Technology Limited has announced a significant leadership change effective December 15, 2025. Mr. Shen Difan, currently serving as an executive director and CEO, has been appointed as the chairman of the board and the chairman of the nomination committee, succeeding Mr. Zhu Shunyan, who has resigned. This move, while deviating from the typical separation of roles as per the Corporate Governance Code, is believed to provide continuity and strong leadership for the company. The board emphasizes maintaining robust oversight to protect shareholder interests and will continue to evaluate the governance structure’s effectiveness.
The most recent analyst rating on (HK:0241) stock is a Sell with a HK$4.60 price target. To see the full list of analyst forecasts on Alibaba Health Information Technology stock, see the HK:0241 Stock Forecast page.
More about Alibaba Health Information Technology
Alibaba Health Information Technology Limited operates in the health information technology industry, focusing on providing healthcare-related services and products through digital platforms. The company is a subsidiary of Alibaba Group, leveraging its technological expertise to enhance healthcare services and expand its market presence.
YTD Price Performance: 60.54%
Average Trading Volume: 85,052,655
Technical Sentiment Signal: Hold
Current Market Cap: HK$86.18B
For an in-depth examination of 0241 stock, go to TipRanks’ Overview page.